Study of BTK Inhibitor BGB-3111 in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM)

Clinical trial NCT03332173 · COMPLETED

Trial details

NCT number: NCT03332173
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Waldenström's Macroglobulinemia (WM)

Start date: 2017-08-31
Primary completion: 2019-05-08
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.